The effects of rhBMP-2 and Treg/Th17 functional disequilibrium in uremic patients with cardiovascular complication after maintenance hemodialysis

International Journal of Artificial Organs

Volumn 36, Issue 7, 2013, Pages 464-472

  Danyan, Chen ^a   Xiaolong, Huang ^b   Song, Lu ^a   Hua, Gan ^c   Weixue, Tang ^d   Ke, Liu ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b Department of Neurosurgery ^*  (China)

^c THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^d CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

MHD Treg Th17; MIP3 CCL20; rhBMP 2; Uremia

Indexed keywords

BIOMINERALIZATION; BONE; CYTOLOGY; HEMODIALYZERS; T-CELLS;

CARDIOVASCULAR EVENT; CELL FUNCTIONS; CORONARY ARTERY CALCIFICATION; HAEMODIALYSIS; HEALTHY CONTROLS; MAINTENANCE HEMODIALYSIS TREG/TH17; MIP3Α/CCL20; RHBMP-2; UREMIA; UREMIC PATIENTS;

DIALYSIS;

MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART FUNCTION; HEMODIALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RISK FACTOR; SCORING SYSTEM; TH17 CELL; UPREGULATION; UREMIA;

EID: 84880948651     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000217     Document Type: Article

References (30)

1. Robinson TG, Carr SJ. Cardiovascular autonomic dysfunction in uremia. Kidney Int. 2002;62(6):1921-1932.
2. Locatelli F, Covic A, Chazot C, Leunissen K, Luño J, Yaqoob M; Accorde Programme. Hypertension and cardiovascular risk assessment in dialysis patients. Nephrol Dial Transplant. 2004;19(5):1058-1068.
3. Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526-1533.
4. Zhang J, Hua G, Zhang X, Tong R, Du X, Li Z. Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events. Nephrology (Carlton). 2010;15(1):33-41.
5. DeLoach SS, Townsend RR. Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol. 2008;3(1):184-192.
6. Mucida D, Park Y, Kim G, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007;317(5835):256-260.
7. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8-27.
8. + regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(4):893-900.
9. Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum. 2008;58(7):2196-2205.
10. de Boer OJ, van der Meer JJ, Teeling P, et al. Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J Pathol. 2010; 220(4):499-508.
11. Chen S, Crother TR, Arditi M. Emerging role of IL-17 in atherosclerosis. J Innate Immun. 2010;2(4):325-333.
12. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007; 8(6):639-646.
13. Sharma UK, Song HF, Willingham FF, et al. Diagnosis of human immunodeficiency virus infection using citrated whole blood. Clin Diagn Lab Immunol. 1997;4(3):261-263.
14. Boström K, Watson KE, Stanford WP, Demer LL. Atherosclerotic calcification: relation to developmental osteogenesis. Am J Cardiol. 1995;75(6):88B-91B.
15. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31(4):607-617.
16. Rostand SG, Drüeke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. 1999;56(2):383-392.
17. Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int. 2004;66(6):2293-2299.
18. Blasi C. The autoimmune origin of atherosclerosis. Atherosclerosis. 2008;201(1):17-32.
19. Nadra I, Mason JC, Philippidis P, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ Res. 2005;96(12):1248-1256.
20. Koleganova N, Piecha G, Ritz E, et al. Arterial calcification in patients with chronic kidney disease. Nephrol Dial Transplant. 2009;24(8):2488-2496.
21. Menten P, Proost P, Struyf S, et al. Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity. Eur J Immunol. 1999;29(2):678-685.
22. Chizzolini C, Chicheportiche R, Alvarez M, et al. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood. 2008;112(9):3696-3703.
23. Negri AL. Vascular calcifications in chronic kidney disease: are there new treatments? Curr Vasc Pharmacol. 2005;3(2): 181-184.
24. Covic A, Kanbay M, Voroneanu L, et al. Vascular calcification in chronic kidney disease. Clin Sci (Lond). 2010;119(3):111-121.
25. Nasir K, Rivera JJ, Yoon YE, et al. Variation in atherosclerotic plaque composition according to increasing coronary artery calcium scores on computed tomography angiography. Int J Cardiovasc Imaging. 2010;26(8):923-932.
26. Csiszar A, Smith KE, Koller A, Kaley G, Edwards JG, Ungvari Z. Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation. 2005;111(18):2364-2372.
27. Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res. 2005;97(2): 105-114.
28. Hauburger A, von Einem S, Schwaerzer GK, et al. The proform of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding. FEBS J. 2009; 276(21):6386-6398.
29. Liao XB, Zhou XM, Li JM, et al. Taurine inhibits osteoblastic differentiation of vascular smooth muscle cells via the ERK pathway. Amino Acids. 2008;34(4):525-530.
30. Al-Aly Z, Shao JS, Lai CF, et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol. 2007;27(12):2589-2596.